Dec 28, 2025
Retinal Vein Occlusion: Risk Factors and Injections Explained
The FDA doesn't rate biosimilars like generics-it evaluates them through a rigorous scientific process to prove they're highly similar and safe. Learn how biosimilars are approved, why they're different from generics, and what the Purple Book means for patients.